Investing.com - Celgene (NASDAQ:CELG) reported first quarter earnings that beat analysts' expectations on Thursday and revenue that topped forecasts.
The firm reported earnings per share of $2.55 on revenue of $4.03B. Analysts polled by Investing.com anticipated EPS of $2.45 on revenue of $4.01B. That compared to EPS of $2.05 on revenue of $3.54B in the same period a year earlier. The company had reported EPS of $2.39 on revenue of $4.04B in the previous quarter.
For the year, Celgene shares are up 46.54%, outperforming the Nasdaq which is up 24.77% year to date.
Celgene follows other major Healthcare sector earnings this month
On Tuesday, April 16, 2019, J&J reported first quarter EPS of $2.1 on revenue of $20.02B, compared to forecasts of EPS of $2.04 on revenue of $19.61B.
Novartis ADR earnings beat analyst's expectations on Wednesday, with first quarter EPS of $1.21 on revenue of $11.11B. Investing.com analysts expected EPS of $1.1 on revenue of $11.4B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar